Septotlet® D (Septolete® D)

Archive
"Trade product
in Russia is not registered "
Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspsugarless lozenges
Composition:

1 lozenge contains:

Active substances:

benzalkonium chloride-1 mg

levomenthol -1.2 mg

thymol 0.6 mg

mint pepper oil - 1 mg

eucalyptus leaf oil - 0.6 mg

Excipients: maltitol liquid, mannitol, castor oil, glycerol, magnesium stearate, silicon dioxide colloid, anhydrous, povidone, dye quinoline yellow (E104), titanium dioxide (E171), wax emulsion, maltitol.

Description:

Round, biconvex pastilles of yellow color.

Pharmacotherapeutic group:Antiseptic.
Pharmacodynamics:
Septollet® D lozenges are a combination of an antiseptic from a group of quaternary ammonium compounds (benzalkonium chloride) and active natural substances (menthol, peppermint essential oil, eucalyptus essential oil, thymol), which increase the activity of the antiseptic and improve its taste.
Benzalkonium chloride has a bactericidal effect on Gram-positive and Gram-negative bacteria, as well as fungicidal action against Candida albicans and certain lipophilic viruses.
Menthol and essential oil of peppermint have a moderate analgesic and deodorant effect.Pastilles relieve pain when swallowing and subjective feelings of discomfort, such as "pershenie." Timol has an antiseptic effect that enhances the effectiveness of the drug.
Essential oil of eucalyptus reduces the secretion of mucus in the upper respiratory tract and facilitates breathing.
The drug Septotelet® D contains polyols (maltitol and mannitol), does not contain sugar, which allows you to take the drug for people with diabetes. The sugarless medium increases the activity of the antiseptic. Maltitol and mannitol are metabolized by oral bacteria very slowly and to a small extent, so they do not have a damaging effect on the enamel of the teeth.
Indications:

Infectious and inflammatory diseases of the mouth and throat:

- pharyngitis, laryngitis, tonsillitis;

- inflammation of the gums and mucous membrane of the mouth (gingivitis, stomatitis).
Contraindications:

- Hypersensitivity to the components of the drug;

- patients with rare hereditary intolerance to fructose;

- children's age up to 4 years.

Carefully:

Diabetes.

Pregnancy and lactation:

Pregnant and breast-feeding women can take Septollet® D lozenges only on the advice of a doctor.Data on the use of the drug during pregnancy and: breastfeeding are limited, so the risk to the fetus and the child is not completely excluded.

Dosing and Administration:

1 lozenge should be slowly dissolved in the oral cavity every 2-3 hours. Children older than 4 years are recommended to take no more than 4 lozenges a day, children older than 10 years are recommended to take no more than 6 lozenges per day. Adults and children over 12 years are recommended to take no more than 8 lozenges per day. The lozenges dissolve until completely dissolved.

Do not take the lozenges immediately before eating, while eating and with milk.

Side effects:

From the digestive system: in very rare cases, nausea, vomiting, diarrhea are possible.

Possible allergic reactions (in patients with increased sensitivity to the components of the drug).

Overdose:

Symptoms: nausea, vomiting and diarrhea (polytol-maltitol and mannitol; glycerol), headache (glycerol).

Treatment: symptomatic.

Interaction:

Benzalkonium chloride is not recommended for use with other antiseptics intended for resorption in the oral cavity.

It is recommended to refrain from the simultaneous reception of Septotelet® D with milk, tk. milk reduces the antiseptic effect of benzalkonium chloride.

Special instructions:

Do not exceed recommended doses.

Septothete® D can be used by patients who have contraindications or restrictions in the intake of sugar-containing preparations.

Patients with diabetes mellitus it should be remembered that each lozenge contains 0.95 g of maltitol. For the metabolism of maltitol, insulin is needed, but since hydrolysis and absorption in the gastrointestinal tract occur slowly, correction of the dose of hypoglycemic drugs is not required. The energy value of maltitol (10 kJ / g or 2.4 kcal / g) is significantly less than that of sucrose.

If the disease is more severe, accompanied by fever, headache and vomiting, it is necessary to see a doctor, especially if the condition does not improve within 3 days after the start of therapy.

Septothete® D lozenges contain glycerol, which in high doses can cause headache and gastrointestinal disorders. Septollet® D bottles also contain polyols (maltitol, mannitol), which in high doses can cause dyspeptic disorders, especially in children.

Septotelet® D contains maltitol; so patients with rare hereditary problems of fructose intolerance should not take the drug.

Effect on the ability to drive transp. cf. and fur:
There is no evidence that the drug Sepotlet ® D has had an impact on the ability to drive and work with complex mechanical means.
Form release / dosage:

Pastilles without sugar.

Packaging:15 lozenges per blister. 2 blisters in a pack of cardboard along with instructions for use.
Storage conditions:

Store in a dry, dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life:

3 years.

Do not use the drug after the expiration date.

Terms of leave from pharmacies:Without recipe
Registration number:П N011475 / 01
Date of registration:02.11.2009
Date of cancellation:2017-04-28
The owner of the registration certificate:KRKA, dd, Novo mesto, AOKRKA, dd, Novo mesto, AO
Manufacturer: & nbsp
KRKA, d.d. Slovenia
Representation: & nbspKRKA KRKA Slovenia
Information update date: & nbsp28.04.2017
Illustrated instructions
    Instructions
    Up